American International Group, Inc. Cue Biopharma, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.77 - $3.09 $270 - $472	-153 Reduced 0.86%	17,735 $33,000
Q4 2023 Feb 13, 2024	BUY	$1.72 - $3.1 $1,100 - $1,984	640 Added 3.71%	17,888 $47,000
Q3 2023 Nov 13, 2023	BUY	$2.23 - $4.69 $1,366 - $2,874	613 Added 3.69%	17,248 $39,000
Q2 2023 Aug 04, 2023	BUY	$3.11 - $4.91 $51,734 - $81,677	16,635 New	16,635 $60,000
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $38,027 - $90,410	-15,272 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.41 - $12.28 $4,745 - $13,213	-1,076 Reduced 6.58%	15,272 $75,000
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $5,299 - $8,710	-488 Reduced 2.9%	16,348 $185,000
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $1,519 - $2,310	151 Added 0.91%	16,836 $245,000
Q2 2021 Aug 13, 2021	SELL	$10.9 - $14.53 $5,777 - $7,700	-530 Reduced 3.08%	16,685 $194,000
Q1 2021 May 07, 2021	BUY	$11.2 - $16.09 $515 - $740	46 Added 0.27%	17,215 $210,000
Q4 2020 Feb 12, 2021	SELL	$11.12 - $16.4 $400 - $590	-36 Reduced 0.21%	17,169 $215,000
Q3 2020 Nov 04, 2020	BUY	$15.05 - $23.54 $3,702 - $5,790	246 Added 1.45%	17,205 $259,000
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $65,303 - $158,013	5,142 Added 43.51%	16,959 $416,000
Q1 2020 May 04, 2020	SELL	$9.85 - $22.27 $6,727 - $15,210	-683 Reduced 5.46%	11,817 $168,000
Q4 2019 Feb 05, 2020	BUY	$7.06 - $17.47 $854 - $2,113	121 Added 0.98%	12,500 $198,000
Q3 2019 Nov 08, 2019	BUY	$6.78 - $9.28 $6,149 - $8,416	907 Added 7.91%	12,379 $104,000
Q2 2019 Aug 13, 2019	SELL	$7.18 - $9.65 $840 - $1,129	-117 Reduced 1.01%	11,472 $103,000
Q1 2019 May 06, 2019	SELL	$4.7 - $9.29 $225 - $445	-48 Reduced 0.41%	11,589 $90,000
Q4 2018 Feb 13, 2019	SELL	$4.35 - $8.73 $391 - $785	-90 Reduced 0.77%	11,637 $55,000
Q3 2018 Nov 09, 2018	BUY	$7.91 - $11.89 $1,669 - $2,508	211 Added 1.83%	11,727 $106,000
Q2 2018 Aug 08, 2018	BUY	$10.93 - $14.48 $63,601 - $84,259	5,819 Added 102.14%	11,516 $137,000
Q1 2018 May 07, 2018	BUY	$11.63 - $17.25 $66,256 - $98,273	5,697 New	5,697 $80,000

Others Institutions Holding CUE

# of Institutions

Shares Held

13.8M

Call Options Held

56.1K

Put Options Held

11.1K

Bleichroeder LP New York, NY

2.86M
Shares

$1.95 Million
1.28% of portfolio
Slate Path Capital LP New York, NY

2.4M
Shares

$1.63 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

2.03M
Shares

$1.38 Million
0.0% of portfolio
Black Rock Inc. New York, NY

757K
Shares

$514,580
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

494K
Shares

$335,911
0.0% of portfolio

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $24.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account